JP2013519875A5 - - Google Patents

Info

Publication number

JP2013519875A5

JP2013519875A5 JP2012552519A JP2012552519A JP2013519875A5 JP 2013519875 A5 JP2013519875 A5 JP 2013519875A5 JP 2012552519 A JP2012552519 A JP 2012552519A JP 2012552519 A JP2012552519 A JP 2012552519A JP 2013519875 A5 JP2013519875 A5 JP 2013519875A5

Authority

JP

Japan

Prior art keywords

sample

reactivity

antigens

pattern

subject

Prior art date

2011-02-13

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000523 sample Substances 0.000 claims 31
• 239000000427 antigen Substances 0.000 claims 28
• 102000036639 antigens Human genes 0.000 claims 28
• 108091007433 antigens Proteins 0.000 claims 28
• 230000009257 reactivity Effects 0.000 claims 28
• 108020004414 DNA Proteins 0.000 claims 16
• 102000053602 DNA Human genes 0.000 claims 16
• 102000008186 Collagen Human genes 0.000 claims 14
• 108010035532 Collagen Proteins 0.000 claims 14
• 229920001436 collagen Polymers 0.000 claims 14
• 238000000034 method Methods 0.000 claims 12
• 102000024905 CD99 Human genes 0.000 claims 10
• 108060001253 CD99 Proteins 0.000 claims 10
• 101001081567 Homo sapiens Insulin-like growth factor-binding protein 1 Proteins 0.000 claims 10
• 102100027636 Insulin-like growth factor-binding protein 1 Human genes 0.000 claims 10
• 201000000596 systemic lupus erythematosus Diseases 0.000 claims 10
• ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 claims 9
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 8
• 229920002674 hyaluronan Polymers 0.000 claims 8
• 229960003160 hyaluronic acid Drugs 0.000 claims 8
• 102000007469 Actins Human genes 0.000 claims 5
• 108010085238 Actins Proteins 0.000 claims 5
• 102100037674 Bis(5'-adenosyl)-triphosphatase Human genes 0.000 claims 5
• 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims 5
• 102100039292 Cbp/p300-interacting transactivator 1 Human genes 0.000 claims 5
• 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 claims 5
• 101000888413 Homo sapiens Cbp/p300-interacting transactivator 1 Proteins 0.000 claims 5
• 102000007460 S100 Calcium-Binding Protein A4 Human genes 0.000 claims 5
• 108010085149 S100 Calcium-Binding Protein A4 Proteins 0.000 claims 5
• 108010005713 bis(5'-adenosyl)triphosphatase Proteins 0.000 claims 5
• 239000013068 control sample Substances 0.000 claims 4
• 235000011330 Armoracia rusticana Nutrition 0.000 claims 3
• 240000003291 Armoracia rusticana Species 0.000 claims 3
• 150000002978 peroxides Chemical class 0.000 claims 3
• 230000003828 downregulation Effects 0.000 claims 2
• 238000007865 diluting Methods 0.000 claims 1
• 230000004043 responsiveness Effects 0.000 claims 1
• 210000002966 serum Anatomy 0.000 claims 1
• 230000003827 upregulation Effects 0.000 claims 1